Article
Three-year outcomes after genotyping-guided treatment switch in HIV patients with virologic failure in Cameroon: Implications for epidemic control in low- and middle-income countries.
Journal of global antimicrobial resistance - 1 Sept 2026
Semengue Ezechiel Ngoufack Jagni, Kuete Chanelle Magnilack, Njouendou Abdel Jelil, Chenwi Collins Ambe, Kenfack Dell-Dylan, Mekel Vincent Kamaël, Njako Joseph Matute, Munge Stella Diabe, Supuen Ladifatou, Berinyuy Linda, Eduke Synthia Njuzy, Tueguem Pamela Patricia, Takou Désiré, Angong Grâce Beloumou, Ndjeyep Sandrine Claire Djupsa, Nka Alex Durand, Christelle Ka'e Aude, Etame Naomi-Karell, Molimbou Evariste, Tekoh Tatiana Anim-Keng, Ngwese Derrick Tambe Ayuk, Fotso Larissa Gaelle Moko, Bissek Anne-Cecile Z-K, Perno Carlo-Federico, Ndembi Nicaise, Fokam Joseph, Ndjolo Alexis
Abstract excerpt
OBJECTIVES: Monitoring of HIV-infected patients with long-term treatment remains challenging in low- and middle-income countries (LMICs) due to risks of multi-class HIV drug resistance (HIVDR). We sought to evaluate the treatment response after a genotypic resistance-guided treatment switch among patients with multi-class HIVDR in Cameroon. METHODS: A retrospective cohort study was conducted in the South-West...
Read the complete abstract on PubMedTopics
- Humans
- Cameroon